CaaMTech Raises $22M in Series A Funding

09 Sep, 2021

CaaMTech Raises $22M in Series A Funding
Photo by STIL on Unsplash

– CaaMTech is a psychedelic drug discovery company.
– The company raised $22M in Series A funding.
– The round was led by Noetic Fund.
– The new investment will be used to support the company’s cross-disciplinary science program, expand its leadership team, and advance its foremost drug development candidates into human trials.

Medical North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: